Guizhou Sanli Pharmaceutical (SHG: 603439)

Guizhou Sanli Pharmaceutical is a corporation based in Guiyang, China. Established in 1995, the firm provides research and development, production, and sales in one of the modern Chinese patent medicine pharmaceutical enterprises. The firm's product line mainly focuses on pediatrics, respiratory system, cardio cerebral vascular department, gastroenterology, and other fields. The assets are managed by the executive management team.